Laboratory Medicine ›› 2023, Vol. 38 ›› Issue (12): 1167-1172.DOI: 10.3969/j.issn.1673-8640.2023.12.011
Previous Articles Next Articles
YANG Xilan1, WANG Jinyu2, LIU Shuyu1, ZHAN Yiyang3, LIU Jing3, JIA Jian3()
Received:
2022-08-08
Revised:
2023-05-04
Online:
2023-12-30
Published:
2024-02-20
CLC Number:
YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing[J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2023.12.011
组别 | 例数 | 体重指数/(kg/m2) | 舒张压/mmHg | 收缩压/mmHg | 吸烟史/ [例(%)] | 饮酒史/ [例(%)] |
---|---|---|---|---|---|---|
高脂血症组 | 100 | 24.35(21.88~25.15) | 10.53(10.13~11.33) | 17.16(16.63~18.09) | 22(22) | 34(34) |
正常对照组 | 100 | 21.88(20.45~22.6) | 10.40(9.60~10.93) | 15.83(15.03~17.16) | 14(14) | 26(26) |
统计值 | -7.011 | -2.445 | -5.744 | 2.168 | 1.524 | |
P值 | <0.001 | 0.015 | <0.001 | 0.142 | 0.219 |
组别 | 例数 | 体重指数/(kg/m2) | 舒张压/mmHg | 收缩压/mmHg | 吸烟史/ [例(%)] | 饮酒史/ [例(%)] |
---|---|---|---|---|---|---|
高脂血症组 | 100 | 24.35(21.88~25.15) | 10.53(10.13~11.33) | 17.16(16.63~18.09) | 22(22) | 34(34) |
正常对照组 | 100 | 21.88(20.45~22.6) | 10.40(9.60~10.93) | 15.83(15.03~17.16) | 14(14) | 26(26) |
统计值 | -7.011 | -2.445 | -5.744 | 2.168 | 1.524 | |
P值 | <0.001 | 0.015 | <0.001 | 0.142 | 0.219 |
组别 | 例数 | TC/(mmol/L) | TG/(mmol/L) | HDL-C/ (mmol/L) | LDL-C/ (mmol/L) | ALT/(U/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
正常对照组 | 100 | 3.47(2.86~4.26) | 1.28(0.91~1.69) | 1.37(1.23~1.65) | 2.21(1.92~2.86) | 24.90(18.10~70.00) | ||||||||
高脂血症组 | 100 | 5.46(5.30~5.86) | 2.76(1.56~4.38) | 0.99(0.48~1.08) | 3.24(2.81~5.06) | 25.60(21.50~31.00) | ||||||||
U值 | -14.379 | -9.962 | 11.071 | -9.800 | -2.748 | |||||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.007 | |||||||||
组别 | AST/(U/L) | BUN/(mmol/L) | SCr/(μmol/L) | UA/(μmol/L) | FBG/(mmol/L) | |||||||||
正常对照组 | 25.00(19.00~28.26) | 5.30(3.92~6.10) | 62.50(52.20~75.80) | 199.00(179.00~266.00) | 5.10(4.64~5.43) | |||||||||
高脂血症组 | 27.00(22.20~33.30) | 5.70(3.80~6.70) | 58.00(46.00~81.00) | 232.00(188.00~274.00) | 5.17(4.65~5.45) | |||||||||
U值 | -3.626 | 0.008 | 0.001 | 0.811 | 0.989 | |||||||||
P值 | <0.001 | 0.056 | 0.216 | 0.432 | 0.842 | |||||||||
组别 | Hb/(g/L) | RBC计数/(×1012/L) | WBC计数/×109/L) | PLT计数/(×109/L) | ||||||||||
正常对照组 | 136.00(132.00~147.00) | 4.12(3.77~4.60) | 5.91(5.10~7.50) | 257.00(189.00~287.00) | ||||||||||
高脂血症组 | 136.00(132.00~144.00) | 4.20(3.70~4.56) | 6.37(5.30~7.33) | 231.00(193.00~251.00) | ||||||||||
U值 | 0.265 | 0.055 | 0.371 | 0.099 | ||||||||||
P值 | 0.609 | 0.866 | 0.368 | 0.783 | ||||||||||
组别 | EMP(%) | hs-CRP(mg/L) | IL-1β(ng/L) | TNF-α(ug/L) | ||||||||||
正常对照组 | 1.70(1.06~2.24) | 0.50(0.50~0.60) | 56.10(40.10~68.77) | 62.30(45.79~78.22) | ||||||||||
高脂血症组 | 2.25(1.43~3.00) | 0.50(0.50~1.77) | 59.46(46.15~78.22) | 75.46(65.50~88.80) | ||||||||||
U值 | -4.093 | 0.001 | 0.065 | 0.432 | ||||||||||
P值 | <0.001 | <0.001 | 0.026 | <0.001 |
组别 | 例数 | TC/(mmol/L) | TG/(mmol/L) | HDL-C/ (mmol/L) | LDL-C/ (mmol/L) | ALT/(U/L) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
正常对照组 | 100 | 3.47(2.86~4.26) | 1.28(0.91~1.69) | 1.37(1.23~1.65) | 2.21(1.92~2.86) | 24.90(18.10~70.00) | ||||||||
高脂血症组 | 100 | 5.46(5.30~5.86) | 2.76(1.56~4.38) | 0.99(0.48~1.08) | 3.24(2.81~5.06) | 25.60(21.50~31.00) | ||||||||
U值 | -14.379 | -9.962 | 11.071 | -9.800 | -2.748 | |||||||||
P值 | <0.001 | <0.001 | <0.001 | <0.001 | 0.007 | |||||||||
组别 | AST/(U/L) | BUN/(mmol/L) | SCr/(μmol/L) | UA/(μmol/L) | FBG/(mmol/L) | |||||||||
正常对照组 | 25.00(19.00~28.26) | 5.30(3.92~6.10) | 62.50(52.20~75.80) | 199.00(179.00~266.00) | 5.10(4.64~5.43) | |||||||||
高脂血症组 | 27.00(22.20~33.30) | 5.70(3.80~6.70) | 58.00(46.00~81.00) | 232.00(188.00~274.00) | 5.17(4.65~5.45) | |||||||||
U值 | -3.626 | 0.008 | 0.001 | 0.811 | 0.989 | |||||||||
P值 | <0.001 | 0.056 | 0.216 | 0.432 | 0.842 | |||||||||
组别 | Hb/(g/L) | RBC计数/(×1012/L) | WBC计数/×109/L) | PLT计数/(×109/L) | ||||||||||
正常对照组 | 136.00(132.00~147.00) | 4.12(3.77~4.60) | 5.91(5.10~7.50) | 257.00(189.00~287.00) | ||||||||||
高脂血症组 | 136.00(132.00~144.00) | 4.20(3.70~4.56) | 6.37(5.30~7.33) | 231.00(193.00~251.00) | ||||||||||
U值 | 0.265 | 0.055 | 0.371 | 0.099 | ||||||||||
P值 | 0.609 | 0.866 | 0.368 | 0.783 | ||||||||||
组别 | EMP(%) | hs-CRP(mg/L) | IL-1β(ng/L) | TNF-α(ug/L) | ||||||||||
正常对照组 | 1.70(1.06~2.24) | 0.50(0.50~0.60) | 56.10(40.10~68.77) | 62.30(45.79~78.22) | ||||||||||
高脂血症组 | 2.25(1.43~3.00) | 0.50(0.50~1.77) | 59.46(46.15~78.22) | 75.46(65.50~88.80) | ||||||||||
U值 | -4.093 | 0.001 | 0.065 | 0.432 | ||||||||||
P值 | <0.001 | <0.001 | 0.026 | <0.001 |
项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
---|---|---|---|---|---|
年龄 | 0.006 | 0.015 | 0.165 | 1.006(0.976~1.037) | 0.684 |
性别 | 0.107 | 0.327 | 0.107 | 1.113(0.586~2.111) | 0.744 |
ALT | 0.058 | 0.022 | 7.105 | 1.059(1.015~1.105) | 0.008 |
AST | 0.075 | 0.022 | 11.835 | 1.078(1.033~1.126) | 0.001 |
BUN | 0.208 | 0.109 | 3.614 | 1.231(0.994~1.526) | 0.057 |
SCr | 0.007 | 0.006 | 1.521 | 1.007(0.996~1.019) | 0.217 |
UA | 0.002 | 0.003 | 0.622 | 1.002(0.997~1.008) | 0.430 |
FBG | 0.053 | 0.265 | 0.040 | 1.055(0.627~1.774) | 0.841 |
Hb | 0.008 | 0.016 | 0.265 | 1.008(0.977~1.041) | 0.607 |
RBC计数 | -0.041 | 0.244 | 0.029 | 0.959(0.594~1.549) | 0.865 |
WBC计数 | 0.082 | 0.091 | 0.815 | 1.086(0.908~1.298) | 0.367 |
PLT计数 | -0.001 | 0.002 | 0.077 | 0.999(0.995~1.004) | 0.781 |
hs-CRP | 0.242 | 0.074 | 10.797 | 1.273(1.102~1.471) | 0.001 |
IL-1β | 0.019 | 0.008 | 4.894 | 1.019(1.002~1.036) | 0.027 |
TNF-α | 0.046 | 0.009 | 24.149 | 1.047(1.028~1.066) | <0.001 |
舒张压 | 0.055 | 0.023 | 5.730 | 1.057(1.010~1.105) | 0.017 |
收缩压 | 0.076 | 0.015 | 25.069 | 1.079(1.047~1.111) | <0.001 |
吸烟史 | 0.550 | 0.376 | 2.137 | 1.733(0.829~3.620) | 0.144 |
饮酒史 | 0.383 | 0.311 | 1.517 | 1.466(0.797~2.696) | 0.218 |
EMP | 0.529 | 0.144 | 13.472 | 1.697(1.280~2.252) | <0.001 |
项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
---|---|---|---|---|---|
年龄 | 0.006 | 0.015 | 0.165 | 1.006(0.976~1.037) | 0.684 |
性别 | 0.107 | 0.327 | 0.107 | 1.113(0.586~2.111) | 0.744 |
ALT | 0.058 | 0.022 | 7.105 | 1.059(1.015~1.105) | 0.008 |
AST | 0.075 | 0.022 | 11.835 | 1.078(1.033~1.126) | 0.001 |
BUN | 0.208 | 0.109 | 3.614 | 1.231(0.994~1.526) | 0.057 |
SCr | 0.007 | 0.006 | 1.521 | 1.007(0.996~1.019) | 0.217 |
UA | 0.002 | 0.003 | 0.622 | 1.002(0.997~1.008) | 0.430 |
FBG | 0.053 | 0.265 | 0.040 | 1.055(0.627~1.774) | 0.841 |
Hb | 0.008 | 0.016 | 0.265 | 1.008(0.977~1.041) | 0.607 |
RBC计数 | -0.041 | 0.244 | 0.029 | 0.959(0.594~1.549) | 0.865 |
WBC计数 | 0.082 | 0.091 | 0.815 | 1.086(0.908~1.298) | 0.367 |
PLT计数 | -0.001 | 0.002 | 0.077 | 0.999(0.995~1.004) | 0.781 |
hs-CRP | 0.242 | 0.074 | 10.797 | 1.273(1.102~1.471) | 0.001 |
IL-1β | 0.019 | 0.008 | 4.894 | 1.019(1.002~1.036) | 0.027 |
TNF-α | 0.046 | 0.009 | 24.149 | 1.047(1.028~1.066) | <0.001 |
舒张压 | 0.055 | 0.023 | 5.730 | 1.057(1.010~1.105) | 0.017 |
收缩压 | 0.076 | 0.015 | 25.069 | 1.079(1.047~1.111) | <0.001 |
吸烟史 | 0.550 | 0.376 | 2.137 | 1.733(0.829~3.620) | 0.144 |
饮酒史 | 0.383 | 0.311 | 1.517 | 1.466(0.797~2.696) | 0.218 |
EMP | 0.529 | 0.144 | 13.472 | 1.697(1.280~2.252) | <0.001 |
项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
---|---|---|---|---|---|
ALT | 0.038 | 0.028 | 1.878 | 1.039(0.984~1.096) | 0.171 |
AST | 0.085 | 0.028 | 9.307 | 1.089(1.031~1.150) | 0.002 |
Hs-CRP | 0.424 | 0.125 | 11.568 | 1.528(1.197~1.951) | 0.001 |
IL-1β | -0.003 | 0.014 | 1.061 | 0.997(0.971~1.023) | 0.805 |
TNF-α | 0.047 | 0.012 | 16.059 | 1.048(1.024~1.072) | <0.001 |
舒张压 | 0.039 | 0.030 | 1.614 | 1.039(0.979~1.103) | 0.204 |
收缩压 | 0.063 | 0.019 | 10.670 | 1.065(1.026~1.106) | 0.001 |
EMP | 0.666 | 0.261 | 6.488 | 1.946(1.166~3.248) | 0.011 |
项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
---|---|---|---|---|---|
ALT | 0.038 | 0.028 | 1.878 | 1.039(0.984~1.096) | 0.171 |
AST | 0.085 | 0.028 | 9.307 | 1.089(1.031~1.150) | 0.002 |
Hs-CRP | 0.424 | 0.125 | 11.568 | 1.528(1.197~1.951) | 0.001 |
IL-1β | -0.003 | 0.014 | 1.061 | 0.997(0.971~1.023) | 0.805 |
TNF-α | 0.047 | 0.012 | 16.059 | 1.048(1.024~1.072) | <0.001 |
舒张压 | 0.039 | 0.030 | 1.614 | 1.039(0.979~1.103) | 0.204 |
收缩压 | 0.063 | 0.019 | 10.670 | 1.065(1.026~1.106) | 0.001 |
EMP | 0.666 | 0.261 | 6.488 | 1.946(1.166~3.248) | 0.011 |
[1] |
LUGO-GAVIDIA L M, BURGER D, MATTHEWS V B, et al. Role of microparticles in cardiovascular disease:implications for endothelial dysfunction,thrombosis,and inflammation[J]. Hypertension, 2021, 77(6):1825-1844.
DOI URL |
[2] |
LEITE A R, BORGES-CANHA M, CARDOSO R, et al. Novel biomarkers for evaluation of endothelial dysfunction[J]. Angiology, 2020, 71(5):397-410.
DOI PMID |
[3] |
PAONE S, BAXTER A A, HULETT M D, et al. Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis[J]. Cell Mol Life Sci, 2019, 76(6):1093-1106.
DOI PMID |
[4] |
YUN J W, BARZEGAR M, BOYER C J, et al. Brain endothelial cells release apical and basolateral microparticles in response to inflammatory cytokine stimulation:relevance to neuroinflammatory stress?[J]. Front Immunol, 2019, 10:1455.
DOI URL |
[5] | 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 血脂异常基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2019, 18(5):406-416. |
[6] |
LA MARCA V, FIERABRACCI A. Insights into the diagnostic potential of extracellular vesicles and their miRNA signature from liquid biopsy as early biomarkers of diabetic micro/macrovascular complications[J]. Int J Mol Sci, 2017, 18(9):1974.
DOI URL |
[7] |
KAJIKAWA M, HIGASHI Y. Triglycerides and endothelial function:molecular biology to clinical perspective[J]. Curr Opin Lipidol, 2019, 30(5):364-369.
DOI URL |
[8] |
BORÉN J, TASKINEN M R, BJÖRNSON E, et al. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia[J]. Nat Rev Cardiol, 2022, 19(9):577-592.
DOI PMID |
[9] |
PIRRO M, SCHILLACI G, PALTRICCIA R, et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia[J]. Arterioscler Thromb Vasc Biol, 2006, 26(11):2530-2535.
PMID |
[10] |
HERMIDA N, BALLIGAND J L. Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress:the role of statins[J]. Antioxid Redox Signal, 2014, 20(8):1216-1237.
DOI URL |
[11] |
ESPOSITO K, CIOTOLA M, SCHISANO B, et al. Endothelial microparticles correlate with endothelial dysfunction in obese women[J]. J Clin Endocrinol Metab, 2006, 91(9):3676-3679.
DOI URL |
[12] |
NORTHROP E F, MILBAUER L C, RUDSER K D, et al. Reproducibility of endothelial microparticles in children and adolescents[J]. Biomark Med, 2019, 14(1):43-51.
DOI URL |
[13] |
PFRIEGER F W, VITALE N. Cholesterol and the journey of extracellular vesicles[J]. J Lipid Res, 2018, 59(12):2255-2261.
DOI PMID |
[14] |
JANSEN F, YANG X, FRANKLIN B S, et al. High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation[J]. Cardiovasc Res, 2013, 98(1):94-106.
DOI PMID |
[15] |
CHIVA-BLANCH G, BADIMON L. Cross-talk between lipoproteins and inflammation:the role of microvesicles[J]. J Clin Med, 2019, 8(12):2059.
DOI URL |
[16] |
STOCKELMAN K A, HIJMANS J G, BAMMERT T D, et al. Circulating endothelial cell-derived microvesicles are elevated with hypertension and associated with endothelial dysfunction[J]. Can J Physiol Pharmacol, 2021, 98(8):557-561.
DOI URL |
[17] |
KAJIKAWA M, HIGASHI Y. Triglycerides and endothelial function:molecular biology to clinical perspective[J]. Curr Opin Lipidol, 2019, 30(5):364-369.
DOI URL |
[1] | SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239. |
[2] | ZHANG Yinwang, LIU Jinyu, SONG Yunxiao, GE Wen, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun. Relationship between preoperative SII and postoperative infection in patients with open fracture after internal fixation [J]. Laboratory Medicine, 2022, 37(11): 1071-1074. |
[3] | LIU Jinyan, ZHAO Juntao, XIANG Mingjie. Mechanism and application of serum amyloid A in clinical diseases [J]. Laboratory Medicine, 2021, 36(7): 756-760. |
[4] | XIAO Yingyan, CUI Yan, LI Yan. Research progress of intestinal microbiota and IL-6/gp130 signaling pathway in acute pancreatitis pathogenesis [J]. Laboratory Medicine, 2021, 36(5): 565-568. |
[5] | ZHANG Shenwei, GUO Jing, ZHANG Zheng, CHEN Jianghong, ZHAO Kui. Roles of ET-1,EMP and hs-cTnT in ischemic heart disease [J]. Laboratory Medicine, 2021, 36(1): 30-33. |
[6] | ZHANG Tao, LIU Qin, LIU Aiping, DING Yaodong. Correlations of NLR and PLR with hyperlipidemia [J]. Laboratory Medicine, 2020, 35(8): 767-770. |
[7] | WANG Rong, HUANG Keliang, ZHANG Jianhua, ZHANG Xin. Establishment and preliminary clinical application of homogeneous method for the determination of remnant lipoprotein-cholesterol [J]. Laboratory Medicine, 2020, 35(5): 464-469. |
[8] | LIU Xiaoni, WANG Ying, LI Taotao, MA Xiaomin, ZHAO Huanlao. Correlation of insulin resistance index and chronic inflammation index in type 2 diabetes mellitus patients with metabolic syndrome [J]. Laboratory Medicine, 2019, 34(9): 826-830. |
[9] | LIU Huifang. Relationship between apolipoprotein E gene polymorphism and blood lipid metabolism in hyperlipidemia patients [J]. Laboratory Medicine, 2018, 33(11): 987-990. |
[10] | LI Yunchun, ZHONG Li, WANG Yue, FANG Zhongjun, DING Liumei, SU Qizhu. Correlations of red blood cell distribution width and related inflammation factors with disease activity in patients with rheumatoid arthritis [J]. Laboratory Medicine, 2017, 32(4): 304-307. |
[11] | REN Runjian, ZHAO Hu, BI Bo. Research progress of peroxisome proliferator-activated receptor gamma in inflammatory-related diseases [J]. Laboratory Medicine, 2017, 32(2): 153-157. |
[12] | GUO Han, ZHANG Jie, YANG Shuo, QIAO Rui. Research progress in the relationship between gut microbiome and human diseases [J]. Laboratory Medicine, 2017, 32(12): 1165-1172. |
[13] | JIANG Xiaohong. Clinical significance of detecting serum adiponectin in patients with acute myocardial infarction [J]. Laboratory Medicine, 2015, 30(6): 585-587. |
[14] | ZHANG Yan,CHEN Xiaoting,SONG Huizhu,QI Zhigang. Research progress on molecular pathogenesis of obesity-induced insulin resistance [J]. , 2014, 29(7): 774-777. |
[15] | LI Liyan, LI Hongchun, MA Ping.. The anti-inflammatory role and mechanism of andrographolide on Pseudomonas aeruginosa-induced lung inflammation in rat model [J]. , 2014, 29(5): 535-539. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||